Results of a recently published long-term follow-up of the ASAP trial, which was conducted at universities and clinics across ...

Patients with acute myeloid leukemia (AML) in remission for over 3 years experience survival rates comparable with a matched cohort from the general population.

Survival rates for childhood leukemia are improving thanks to new treatments. Acute lymphoblastic leukemia has the highest survival among all pediatric cancers, 80-85 percent. Seattle Children’s ...

Tecartus demonstrated similar effectiveness across age groups of patients with relapsed or refractory B-cell acute lymphoblastic leukemia. Tecartus (brexucabtagene autoleucel) produced similar ...

The selection of patients for allo-HSCT and the best approach to bridging patients to transplantation is continuously ...

A study from a major cancer center collected data on 2857 patients with Ph+ CML, most of whom were White and middle-aged. Ten-year overall survival for patients with Ph+ CML treated since 2000 was ...

The authors found comparable results among patients in all 3 donor categories. For instance, the 2-year overall survival (OS) ...

B-PLL is a rare subtype that’s more aggressive than other blood cancers and has a low survival rate. However, ongoing research and clinical trials may offer new treatment options to improve outcomes.

Although treatment for leukemia can be complicated and the cure success rate can vary based on a patient’s age and overall health, oncologists are hopeful that recent strides in treatment may have an ...